Stay updated with breaking news from Strides Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The product is bioequivalent and therapeutically equivalent to the reference listed drug Vascepa of Amarin. It will be manufactured at the company's facility in Bengaluru, it added. The Icosapent Ethyl capsules have a market size of around USD 1.3 billion, Strides said, citing IQVIA.
ICICI Securities recommended reduce rating on Strides Pharma Science with a target price of Rs 495 in its research report dated September 26, 2023.
Sharekhan recommended Hold rating on Strides Pharma Science with a target price of Rs 600 in its research report dated September 26, 2023.
Stocks that were in focus included names like Strides Pharma, which fell 1.84%, Tata Steel, which rose 1.22%, and Sun TV, whose shares declined 1.28% on Tuesday.
India Business News: Pharmaceutical company Strides Pharma has received board approval for a scheme of arrangement to create a separate contract development and manufactur